Binkow & Goldberg LLP , representing investors of Rayonier,
Inc. (“Rayonier” or the “Company”) (NYSE:RYN), has filed a class
action lawsuit in the United States District Court for the Middle
District of Florida on behalf of a class (the “Class”) comprising
purchasers of Rayonier securities between January 27, 2014 and November
7, 2014, inclusive (the “Class Period”).
Please contact Lesley
Portnoy or Casey
Sadler at (310) 201-9150, or at firstname.lastname@example.org
to discuss this matter.
USA (HomeServe), a leading provider of home emergency repair service
plans, today announced the details of its new agreement with City of
Sioux City Public Works to provide optional home emergency protection
plans to Sioux City residents.
Clovis Oncology (NASDAQ:CLVS) announced today updated findings from its
ongoing Phase 2 clinical study of rociletinib (CO-1686), the Company’s
novel, oral, targeted covalent (irreversible) mutant-selective inhibitor
of the epidermal growth factor receptor (EGFR) for the treatment of
NSCLC in patients with initial activating EGFR mutations as well as the
primary resistance mutation T790M.
Sign-up for Interim Data from Rociletinib (CO-1686) Phase 1/2 Study Shows Compelling and Durable Clinical Activity and Progression-free Survival (PFS) in Patients with EGFR-Mutant Non-small Cell Lung Cancer (NSCLC) investment picks
Sciences Corporation (NYSE: ORB), one of the world’s leading space
technology companies, today announced that its Technical Services
Division (TSD) in Greenbelt, MD was awarded a contract by the National
Aeronautics and Space Administration (NASA) to operate the space
agency’s Science Balloon Operations program.
CHARLOTTE, NC--(Marketwired - November 14, 2014) - Chanticleer Holdings, Inc. (NASDAQ: HOTR) ("Chanticleer," or the "Company"), owner and operator of multiple restaurant brands internationally and domestically, announces its financial results for the third quarter ended September 30, 2014 ("Q3").
"We are pleased to report that as a company we achieved a significant milestone of positive adjusted EBITDA for the third quarter.
The Dow Chemical Company (NYSE: DOW) announced today that its Board of
Directors has declared a 14 percent increase in the Company’s dividend,
from $0.37 per share to $0.42 per share in the fourth quarter.
Pfizer Inc. announced today that it will present data for several of its
marketed and investigational medicines for inflammatory and
immunological conditions at the American College of Rheumatology (ACR) /
Association of Rheumatology Health Professionals (ARHP) 2014 Annual
Meeting (November 14-19, Boston, Massachusetts). Twenty-one abstracts
for XELJANZ ® (tofacitinib citrate) will be presented,
including the six-year safety and efficacy analyses from long-term
extension (LTE) studies and a summary of real-world patient experience,
additional post-hoc analyses from the clinical development program, and
health and economics outcomes research, adding to the substantial body
of evidence for XELJANZ as an oral treatment option for moderate to
severe rheumatoid arthritis (RA). Data will also be presented for
several additional Pfizer assets, including PF-04236921, an
Rite Aid announced today it has entered into an agreement with HealthSpot ® ,
a pioneer in patient and provider driven healthcare technology, to
provide convenient healthcare services via private, walk-in HealthSpot
stations inside select Rite Aid locations.
Accenture (NYSE:ACN) and SAP SE (NYSE:SAP) today announced a new version
of the SAP® Upstream Operations Management application, which enables
oil and gas companies to improve the accuracy of production data and
identify production-optimization opportunities.
Derma Sciences, Inc. (Nasdaq:DSCI), a tissue regeneration company
focused on advanced wound and burn care, today announced that on October
31, 2014 the Centers for Medicare and Medicaid Services (CMS) issued the
final rule for hospital outpatient prospective payment to take effect
January 1, 2015.
Aetna (NYSE: AET) is expanding its presence in the Federal Employees
Health Benefit Program (FEHBP) with two new options: a new Aetna Direct
plan designed for federal retirees; and a new joint venture between
Aetna and Inova Health Systems called Innovation Health.
Independent. Insightful. Trusted. Morningstar provides stock market analysis; equity, mutual fund, and ETF research, ratings, and picks; portfolio tools; and option, hedge fund, IRA, 401k, and 529 plan research. Our reliable data and analysis can help both experienced enthusiasts and newcomers.